Detalles de la búsqueda
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 403(10442): 2416-2425, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763153
2.
Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.
Future Oncol
; 10(14): 2227-41, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25471036
3.
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).
Int J Radiat Oncol Biol Phys
; 119(1): 100-109, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979707
4.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19â¯Gy or two fractions of 13.5â¯Gy: A 9-year update.
Radiother Oncol
; : 110381, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38879130
5.
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Radiother Oncol
; 184: 109672, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059334
6.
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.
Pract Radiat Oncol
; 12(6): e531-e537, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718075
7.
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost.
Int J Radiat Oncol Biol Phys
; 112(3): 735-743, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637882
8.
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI.
Clin Transl Radiat Oncol
; 32: 41-47, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841094
9.
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Radiother Oncol
; 169: 51-56, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151715
10.
A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer.
BJU Int
; 108(8 Pt 2): E164-70, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21435153
11.
Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis.
Radiother Oncol
; 154: 118-122, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966843
12.
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial.
Radiother Oncol
; 156: 160-165, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359269
13.
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.
Radiother Oncol
; 161: 159-165, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119585
14.
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life.
Radiother Oncol
; 161: 40-46, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089752
15.
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials.
Radiother Oncol
; 163: 159-164, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487764
16.
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.
Radiother Oncol
; 163: 21-31, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324914
17.
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost.
Radiother Oncol
; 154: 29-35, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918971
18.
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging.
Adv Radiat Oncol
; 6(1): 100553, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33521396
19.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy.
Radiother Oncol
; 146: 90-96, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32146259
20.
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
Radiother Oncol
; 142: 236-245, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31543287